{"url_path":"/sec/btai/10-q/2026/item-2","section_key":"item-2","section_title":"Item 2 ****Unregistered Sales of Equity Securities, and Use of Proceeds**","topic":"sec","document":{"doc_type":"10-Q","doc_date":"2026-05-15","source_url":"https://www.sec.gov/Archives/edgar/data/1720893/0001104659-26-061769-index.html","accession_number":"0001104659-26-061769","cik":"0001720893","ticker":"BTAI","issuer_name":"BioXcel Therapeutics, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1720893/0001104659-26-061769-index.html","primary_entity_key":"0001720893","primary_entity_name":"BioXcel Therapeutics, Inc."},"word_count":12,"has_tables":true,"body_markdown":"**Item 2.****Unregistered Sales of Equity Securities, and Use of Proceeds**\n\n​\n\nNone."}